The agenda, keynote presentations, and more are announced for this year’s CONVERGENCE ’24 conference.
In a recent press release, the Council for Responsible Nutrition (CRN; Washington, D.C.) announced the opening keynote speaker for its CONVERGENCE ’24 conference, taking place October 9–11, 2024, in Salt Lake City, Utah, at the Grand America Hotel. On October 10, the Food and Drug Administration’s (FDA) Deputy Commissioner for Human Foods, Jim Jones will be presenting on dietary supplement oversight and the agency’s new framework, enforcement priorities, and possible legislative updates to the Dietary Supplement Health and Education Act (DSHEA) the agency would support.
Also presenting at CONVERGENCE ’24 are Noelle Russell, Founder and Chief AI Officer of AI Leadership Institute and Chris Cillizza, former CNN Politics reporter.
“CRN’s carefully curated program of keynote speakers for CONVERGENCE ‘24 is designed to help keep supplement industry stakeholders connected to the latest developments at FDA, inspire innovation sparked by discussions around the future of AI, and make sense of what today’s headlines portend for the global political landscape,” stated CRN President and CEO Steve Mister, in the press release. “And, of course, attendees will enjoy the ample opportunities for networking and conversation about what’s next for our industry as we celebrate the 30th anniversary of DSHEA.”
Prior to the keynote presentations, several other events will take place on October 9, including the first Innovation Exchange, six 25-minute presentations on ingredient research and innovation, manufacturing, and more.
Additionally, the WellComms forum, an event for marketing and communications professionals, will feature presentations on the latest trends and strategies in the supplement industry based on new consumer behaviors.
Finally, the theme for this year’s Science in Session is “Living Well Longer: Bioactive Innovations for Healthy Aging,” and will cover topics such as research on bioactives for healthy longevity, cognition, bone and skin health, inflammation and obesity, and others.
The agenda includes the following presentations:
Registration for these events is open to both members and non-members and can be found at www.crnusa.org/2024events.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.